ACH

Accendra Health, Inc. (ACH) SWOT Analysis Analysis (2026)

Invetso Score: 4.2/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Strengths

Score: 5.8 (Moderate)

Negative cash conversion cycle of -53.3 days supports working-capital efficiency versus peers, but the advantage is less durable in a commodity-linked business.

ROIC of 6.4% indicates modest capital productivity, which is better than distressed peers but still trails stronger specialty chemical operators.

Limited disclosed margin data prevents a fuller peer read, yet the available efficiency metrics suggest operational discipline rather than structural pricing power.

The balance-sheet profile is not a strength, so the main internal support comes from cash generation efficiency relative to peers rather than superior profitability.

Weaknesses

Score:

Net debt to EBITDA of 7.7x signals heavy leverage, leaving ACH materially weaker than most peers on financial flexibility and resilience.

Current ratio of 0.41x and quick ratio of 0.30x indicate tight liquidity, which constrains working-capital absorption versus better-capitalized competitors.

The negative debt-to-equity reading reflects a strained equity base, reinforcing a weaker capital structure than peers with healthier balance sheets.

Low ROIC relative to the cost of capital implies limited internal reinvestment capacity, which weakens long-term positioning against higher-return peers.

Opportunities

Score:

If ACH sustains its negative cash conversion cycle, it can continue funding operations with less external capital than peers that tie up more cash in working capital.

Any improvement in leverage would have an outsized effect on competitiveness because highly indebted peers typically face higher financing costs and tighter strategic options.

Operational gains that lift ROIC would matter more here than for stronger peers, since even modest efficiency gains can improve capital allocation flexibility.

The absence of segment concentration data limits visibility, but any portfolio simplification could improve comparability versus more complex peers.

Threats

Score:

High leverage makes ACH more vulnerable than peers to cyclical downturns, because earnings volatility can quickly pressure covenant headroom and refinancing access.

Weak liquidity increases execution risk versus better-capitalized competitors, especially if working-capital needs rise or customer payments slow.

Lower ROIC than stronger peers raises the risk of value destruction if capital must be deployed into low-return projects to defend market position.

Without evidence of diversified segment exposure, ACH may remain more exposed than peers to pricing pressure in its core end markets.

Overall Score

Score:

ACH shows some working-capital efficiency, but its weak liquidity and heavy leverage leave its structural positioning below stronger peers overall.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Accendra Health, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →